• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膳食果糖的肠道分解代谢通过回肠乳糜管重塑促进肥胖和胰岛素抵抗。

Intestinal catabolism of dietary fructose promotes obesity and insulin resistance via ileal lacteal remodeling.

作者信息

Lopez Miranda L, Kang Taekyung, Espeleta Ana, Rubtsova Varvara I, Baek Jongwon, Songcuan Jakob, Moyer Elena M, Kim Joohwan, Song Won-Suk, Jung Sunhee, D'Sa Nicholas, Anica Alexis, Tran Elise, Chun Yujin, Choi Wonsuk, Jang Ki-Hong, Kelly Miranda E, Tamburini Ian J, Alam Yasmine H, Le Johnny, Ramirez Cuauhtemoc B, Kataru Raghu P, Hong Seon Pyo, Nicholas Dequina A, Xue Katherine S, Lee Gina, Bae Hosung, Jang Cholsoon

机构信息

Department of Biological Chemistry, Center for Epigenetics and Metabolism, Chao Family Comprehensive Cancer Center, School of Medicine, University of California Irvine, Irvine, CA 92617.

Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA 92617.

出版信息

bioRxiv. 2025 Aug 22:2025.08.18.670963. doi: 10.1101/2025.08.18.670963.

DOI:10.1101/2025.08.18.670963
PMID:40894608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12393376/
Abstract

High-fructose corn syrup (HFCS) consumption is a risk factor for obesity and metabolic syndrome, yet the underlying mechanisms are incompletely understood. Catabolism of dietary fructose primarily occurs in the small intestine and liver, with fructose breakdown in the liver being pathological, while small intestinal fructose clearance protects the liver. Here, we unexpectedly found that inhibition of fructose catabolism specifically in the small intestine mitigates fructose-induced obesity and insulin resistance. Mechanistically, blocking intestinal fructose catabolism reduces dietary fat absorption, which is associated with a decrease in the surface area of the ileal lacteals and alterations in gut microbiome. Fecal transplantation experiments revealed that such a microbiome stimulates the intestine-resident macrophages, promoting lacteal growth and boosting dietary fat absorption. Given the preclinical and clinical studies reporting the effect of fructose catabolism suppression on mitigating diet-induced obesity, our data suggest that such effects are partly mediated by intestinal lacteal remodeling.

摘要

食用高果糖玉米糖浆(HFCS)是肥胖和代谢综合征的一个风险因素,但其潜在机制尚未完全明确。膳食果糖的分解代谢主要发生在小肠和肝脏,肝脏中的果糖分解具有病理性,而小肠对果糖的清除则可保护肝脏。在此,我们意外地发现,特异性抑制小肠中的果糖分解代谢可减轻果糖诱导的肥胖和胰岛素抵抗。从机制上讲,阻断肠道果糖分解代谢可减少膳食脂肪吸收,这与回肠乳糜管表面积的减少以及肠道微生物群的改变有关。粪便移植实验表明,这样的微生物群会刺激肠道驻留巨噬细胞,促进乳糜管生长并增加膳食脂肪吸收。鉴于临床前和临床研究报告了果糖分解代谢抑制对减轻饮食诱导的肥胖的作用,我们的数据表明,这种作用部分是由肠道乳糜管重塑介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/12393376/0289ec1e4fe8/nihpp-2025.08.18.670963v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/12393376/ba715b5467c4/nihpp-2025.08.18.670963v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/12393376/62e0fd38d874/nihpp-2025.08.18.670963v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/12393376/d1aef2453716/nihpp-2025.08.18.670963v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/12393376/0289ec1e4fe8/nihpp-2025.08.18.670963v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/12393376/ba715b5467c4/nihpp-2025.08.18.670963v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/12393376/62e0fd38d874/nihpp-2025.08.18.670963v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/12393376/d1aef2453716/nihpp-2025.08.18.670963v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/12393376/0289ec1e4fe8/nihpp-2025.08.18.670963v1-f0004.jpg

相似文献

1
Intestinal catabolism of dietary fructose promotes obesity and insulin resistance via ileal lacteal remodeling.膳食果糖的肠道分解代谢通过回肠乳糜管重塑促进肥胖和胰岛素抵抗。
bioRxiv. 2025 Aug 22:2025.08.18.670963. doi: 10.1101/2025.08.18.670963.
2
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.由饮食信号驱动的表达T-bet的Tr1细胞主导小肠免疫格局。
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
3
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate.膳食果糖通过微生物群衍生的乙酸促进肝脏脂肪生成。
Nature. 2020 Mar;579(7800):586-591. doi: 10.1038/s41586-020-2101-7. Epub 2020 Mar 18.
4
Intestinal FFA3 mediates obesogenic effects in mice on a Western diet.肠道游离脂肪酸受体 3 介导西方饮食诱导的肥胖效应。
Am J Physiol Endocrinol Metab. 2022 Sep 1;323(3):E290-E306. doi: 10.1152/ajpendo.00016.2022. Epub 2022 Jul 20.
5
Sustained ACE2 Expression by Probiotic Improves Integrity of Intestinal Lymphatics and Retinopathy in Type 1 Diabetic Model.益生菌持续表达血管紧张素转换酶2可改善1型糖尿病模型的肠道淋巴管完整性和视网膜病变。
J Clin Med. 2023 Feb 23;12(5):1771. doi: 10.3390/jcm12051771.
6
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.基于肠道微生物群的干预措施用于管理19岁及以下儿童和青少年的肥胖问题。
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
7
Dietary Manganese Modulates Microbiota and Intestinal N-Acylethanolamines in a Sex-Specific Manner in Mice With Diet-Induced Obesity.膳食锰以性别特异性方式调节饮食诱导肥胖小鼠的微生物群和肠道N-酰基乙醇胺。
FASEB J. 2025 Jul 15;39(13):e70763. doi: 10.1096/fj.202500934R.
8
Dietary interventions for recurrent abdominal pain in childhood.儿童复发性腹痛的饮食干预措施
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD010972. doi: 10.1002/14651858.CD010972.pub2.
9
Supplementation of the maternal diet during pregnancy with chocolate and fructose interacts with the high-fat diet of the young to facilitate the onset of metabolic disorders in rat offspring.孕期母体饮食中补充巧克力和果糖会与幼鼠的高脂肪饮食相互作用,促进子代代谢紊乱的发生。
Clin Exp Pharmacol Physiol. 2013 Sep;40(9):652-61. doi: 10.1111/1440-1681.12147.
10
Caffeic acid modulates intestinal microbiota, alleviates inflammatory response, and enhances barrier function in a piglet model challenged with lipopolysaccharide.咖啡酸调节仔猪模型的肠道微生物群,减轻炎症反应,增强屏障功能,对抗脂多糖。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae233.

本文引用的文献

1
Discovery of GLP-1-Based Drugs for the Treatment of Obesity.用于治疗肥胖症的基于胰高血糖素样肽-1的药物的发现。
N Engl J Med. 2025 Feb 6;392(6):612-615. doi: 10.1056/NEJMcibr2409089. Epub 2024 Sep 19.
2
Discovery of a Novel Ketohexokinase Inhibitor with Improved Drug Distribution in Target Tissue for the Treatment of Fructose Metabolic Disease.发现一种新型酮己糖激酶抑制剂,可改善靶组织中的药物分布,用于治疗果糖代谢疾病。
J Med Chem. 2023 Oct 12;66(19):13501-13515. doi: 10.1021/acs.jmedchem.3c00715. Epub 2023 Sep 27.
3
Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration.
小肠与结肠的生态与生理学:在益生菌给药中的意义。
Cell Rep Med. 2023 Sep 19;4(9):101190. doi: 10.1016/j.xcrm.2023.101190. Epub 2023 Sep 7.
4
Cancer cachexia: molecular mechanisms and treatment strategies.癌症恶病质:分子机制与治疗策略。
J Hematol Oncol. 2023 May 22;16(1):54. doi: 10.1186/s13045-023-01454-0.
5
Fructose drives de novo lipogenesis affecting metabolic health.果糖促进从头合成脂肪影响代谢健康。
J Endocrinol. 2023 Mar 27;257(2). doi: 10.1530/JOE-22-0270. Print 2023 May 1.
6
Fructose might be a clue to the origin of preeclampsia insights from nature and evolution.果糖可能是子痫前期起源的线索:来自自然和进化的见解。
Hypertens Res. 2023 Mar;46(3):646-653. doi: 10.1038/s41440-022-01121-w. Epub 2022 Dec 20.
7
Dietary Fructose and Fructose-Induced Pathologies.膳食果糖与果糖诱导的病理生理学改变
Annu Rev Nutr. 2022 Aug 22;42:45-66. doi: 10.1146/annurev-nutr-062220-025831.
8
Lipid absorption and overall intestinal lymphatic transport are impaired following partial small bowel resection in mice.部分小肠切除术后,小鼠的脂类吸收和整体肠道淋巴转运受损。
Sci Rep. 2022 Jul 7;12(1):11527. doi: 10.1038/s41598-022-15848-6.
9
HarmonizR enables data harmonization across independent proteomic datasets with appropriate handling of missing values.HarmonizR 支持对独立蛋白质组学数据集进行数据协调,并适当处理缺失值。
Nat Commun. 2022 Jun 20;13(1):3523. doi: 10.1038/s41467-022-31007-x.
10
Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial.非酒精性脂肪性肝病成人中酮己糖激酶的抑制作用可减少肝脂肪和炎症标志物:一项随机 2 期试验。
Med. 2021 Jul 9;2(7):800-813.e3. doi: 10.1016/j.medj.2021.04.007. Epub 2021 Apr 27.